Fact CheckerSign in

NCT07538505Not yet recruiting

Testing a Diabetes Care Program in Rural and Low-Income Clinics

Implementing a Diabetes Intervention in Rural and Low-Income Clinics: A Feasibility Study

Source: ClinicalTrials.gov · Last updated 14 Aug 2026

Brief summary (registry, in English)

The goal of this study is to evaluate a Community Health Worker (CHW) program for people living with diabetes in rural areas or locations that are remote from the research team. The study aims to answer the following questions: 1. Does the CHW program improve diabetes-related health outcomes, such as blood sugar control? 2. What is the sustainability of the program? 3. Is the program feasible and acceptable? Participants will be invited to attend monthly diabetes education classes led by CHWs and receive weekly mobile health check-ins from CHWs for coaching and to help coordinate care with their clinic team.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
13 Apr 2026
Start date
1 Mar 2027
Primary completion date
28 Feb 2028
Lead sponsor
The University of Texas Medical Branch, Galveston
NCT number
NCT07538505

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 1 Mar 2027 to the primary completion date, 28 Feb 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe mental illness or cognitive impairment that would preclude participation in group activities
  • Type 1 diabetes mellitus

Lab values

  • Condition known to alter HbA1c levels, e.g., recent transfusion, systemic steroids

Other

  • Pregnancy during the intervention period

Who the study is looking for

  • Self-identified Hispanic Ethnicity
  • Spanish-speaking
  • Type 2 diabetes diagnosis, .g., physician documented diagnosis, HbA1c at least 6.5, treatment with a glucose-lowering agent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.